Belzutifan offers hope for patients with von Hippel-Lindau disease
The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.
December 16, 2021 5:00 AM
Jordyn Imhoff
Public Relations Representative
(She/Her)
Imhoff, the team's Diabetes/Endocrinology, Kellogg Eye Center, Nephrology and Rheumatology communicator, joined Michigan Medicine in 2019. She's passionate about storytelling and brand activism. Twitter: @JordynImhoff
6 management habits to reduce disparities in pediatric type 1 diabetes
In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.
November 22, 2021 10:01 AM
Risk of PTSD, anxiety, loneliness after COVID-19 hospitalization
Research finds COVID-19 associated with mental health problems after discharge, with majority not recognizing significant symptoms as a concern.
November 02, 2021 10:10 AM
No more finger pricks: a continuous glucose monitor benefits patients with diabetes in more ways than one
For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.
July 20, 2021 1:47 PM
Precision medicine helps identify “at-risk rapid decliners” in early-stage kidney disease
A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.
July 08, 2021 8:00 AM
Opioid use after eye surgery correlates to new, persistent use in previously opioid-naïve patients
An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.
June 24, 2021 5:00 AM
More Authors
Beata Mostafavi
Public Relations Manager